The Latest Breaking News from William Blair

On Wednesday, the Centers for Medicare Medicaid Services (CMS) proposed a significant step toward broader adoption of renal denervation (RDN) by offering coverage for both radiofrequency (rfRDN) and ultrasound (uRDN) technologies for uncontrolled hypertension. This coverage would be granted under a Coverage with Evidence Development (CED) framework, requiring treatment within…

Tesla stock lost nearly 7% Monday after Elon Musk announced plans of launching the “America Party.” William Blair downgraded TSLA shares.

This nuclear stock has received a positive analyst rating after a favorable announcement from the government.

President Donald Trump signed executive orders to support the nuclear industry last week.

Amazon stock rallied last week on hopes the Trump China tariffs will be reversed or lowered.

Elon Musk's departure from DOGE may brighten the outlook for military IT contractors such as Booz Allen Hamilton.

A William Blair analyst says Palantir stock is positioned for near-term gains. Should you buy the recent dip in PLTR shares then?

Palantir is poised to win a U.S. Army contract that could eventually deliver annual recurring revenue approaching $100 million, said a William Blair analyst.

A continued rout in Palantir stock made one of its long-time skeptics change his stance on the big data analytics firm on Wednesday.